Table 2.
Group | P-gp | TGF-β1 | PKCα | |
---|---|---|---|---|
Membrane | Plasma | |||
Carcinoma | 35 (83.3%) | 34 (80.9%) | 25 (59.5%) | 22 (52.3%) |
Non-cancer | 7 (16.7%)* | 8 (19.1%)* | 2 (4.8%)* | 35 (83.3%)* |
*P < 0.01
Group | P-gp | TGF-β1 | PKCα | |
---|---|---|---|---|
Membrane | Plasma | |||
Carcinoma | 35 (83.3%) | 34 (80.9%) | 25 (59.5%) | 22 (52.3%) |
Non-cancer | 7 (16.7%)* | 8 (19.1%)* | 2 (4.8%)* | 35 (83.3%)* |
*P < 0.01